Principal product lines include needles, syringes and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for the self-injection of insulin and other drugs used in the treatment of diabetes; prefillable drug delivery devices provided to pharmaceutical companies and sold to end-users as drug/device combinations; surgical blades/ scalpels and regional anesthesia needles and trays; critical care monitoring devices; ophthalmic surgical instruments; sharps disposal containers; and home healthcare products such as ACE brand elastic bandages.
BD Medical’s business strategy is focused on effectively addressing four global health needs:
Preventing the spread of infection...with an extensive line of safety-engineered devices to reduce the risk of sharps injuries to healthcare workers around the world – a field in which BD is a global leader. We provide innovative IV flush syringes and closed IV catheter systems designed to enhance patient safety by reducing the potential for medical errors and device contamination while promoting healthcare worker safety. We also offer low-cost, auto-disabling injection devices for immunization and parenteral therapies, intended to prevent disease spread associated with syringe reuse in developing countries.
Enhancing diabetes treatment...by offering the world’s leading devices for insulin injection and award-winning educational programs to help people with diabetes help themselves. BD developed the first syringe dedicated to insulin delivery in 1924 and has made continuous advances ever since, developing a deep understanding of the needs, preferences and lifestyles of those who self-inject insulin. Today’s insulin injection needles are tiny and virtually pain-free. Insulin injection offers precise dose control to help patients achieve tighter control of their blood glucose levels, which helps reduce the risk of complications from diabetes. We are increasing insulin pen needle manufacturing capacity to meet the rising global prevalence of diabetes, and we are expanding application of these products for both insulin and non-insulin diabetes treatments.
Advancing drug delivery...as the category leader in prefillable devices, BD works with more than 200 pharmaceutical companies. Injectable drugs sold in glass and plastic prefilled syringe formats reduce the potential for medication error and contamination while providing drug companies with a means to differentiate their offerings. Two areas of innovation include an advanced “Micro-Delivery” platform for injection of vaccines that may offer important therapeutic advantages over conventional injection methods, and self-injection devices to ease administration of injectable drugs by patients in a home setting.
Improving ophthalmic surgery outcomes...through new technologies that enhance blade sharpness while protecting ophthalmic surgeons and their staffs from occupational injury. We offer single-use knives, surgical instruments and procedure packs as well as other ophthalmic accessories.